In this review, we examine all our observations concerning the use of compounds, natural, synthetic, multi-targeted, and single-targeted, that act as pharmacological targets of NF-κB and that were conducted on MDR cancer models (Figure 1). This evidence concerns the gene NFKB1 and cancer.